Michigan Biosciences Industry Association Logo

Advocacy

Stay informed on advocacy efforts driving growth and innovation in the bio-industry. This category features updates, initiatives, and insights focused on promoting policies and actions that support our thriving community.

Advocacy Advocacy : Federal Advocacy Advocacy : State Advocacy Association Updates BioConnections® Jobs Event Event : Industry Event Event : MichBio Advocacy Events Event : MichBio Networking Event Event : MichBio Signature Event Event : MichBio Webinar Event : Partner Event Member Feature News News : Industry News News : Member News News : MichBio News/Statement News : Michigan News
SBIR/STTR Reauthorization Advances to President's Desk
Posted In: Federal Advocacy,
Date posted Mar 20

The future of the SBIR/STTR programs has been a critical issue for the life sciences innovation ecosystem, as highlighted in prior biolink...

Read Post
FDA Signals Shift Toward Human-Based Drug Testing as NIH Commits to $150M to Alternatives
Posted In: Federal Advocacy,
Date posted Mar 20

The U.S. drug development landscape is entering a pivotal transition, as federal regulators and research funders accelerate efforts to reduce...

Read Post
EPA Moves to Rescind Biden-Era Ethylene Oxide Limits, Reigniting Debate Over Safety and Supply Chain
Posted In: Federal Advocacy,
Date posted Mar 20

A new proposal from the U.S. Environmental Protection Agency (EPA) is reshaping the regulatory landscape for medical device sterilization -...

Read Post
U.S. Senate Advances SBIR/STTR Reauthorization, Restoring a Critical Innovation Pipeline
Posted In: Federal Advocacy,
Date posted Mar 6

After months of uncertainty for startups and technology innovators across the country, the U.S. Senate has passed bipartisan legislation, S....

Read Post
House Biotech Caucus Endorses Key Biotechnology and Biomanufacturing Legislation
Posted In: Federal Advocacy,
Date posted Mar 6

The bipartisan House BIOtech Caucus recently announced its first-ever legislative endorsements, backing two bills aimed at strengthening U.S....

Read Post
MichBio Hosts Double-Header at the Capitol: Advancing Bioscience Policy and Partnerships
Posted In: State Advocacy,
Date posted Mar 6

MichBio welcomed Michigan legislators, staff, and industry leaders to Lansing last week for a pair of back-to-back events highlighting the...

Read Post
Codifying MFN Drug Pricing Could Undermine Biopharma Innovation
Posted In: Federal Advocacy,
Date posted Feb 20

As Congress considers whether to codify Most Favored Nation (MFN) drug pricing into statute, recent comments by CMS Administrator Dr. Mehmet Oz...

Read Post
FDA to Adopt Single-trial Default Policy: Implications for Biopharma and Vaccine Innovation
Posted In: Federal Advocacy,
Date posted Feb 20

The U.S. Food and Drug Administration (FDA) has announced a significant shift in its drug approval standards, moving away from the long-standing...

Read Post
MichBio Backs Renewal of Michigan's SmartZone TIF Authority
Posted In: State Advocacy,
Date posted Feb 20

MichBio is proud to voice strong support for HB 5031, legislation that would renew the Tax Increment Financing (TIF) authority underpinning...

Read Post
MichBio Supports SB 704 to Establish State Cannabis Reference Laboratory
Posted In: State Advocacy,
Date posted Feb 20

MichBio has expressed strong support for SB 704, legislation that would establish a State Reference Laboratory to strengthen oversight,...

Read Post
HB 4878 Advances - But 340B Transparency Questions Remain Unresolved
Posted In: State Advocacy,
Date posted Feb 6

Michigan House Bill 4878 cleared the House Health Policy Committee this week, advancing with a committee substitute (H-3) and moving next to...

Read Post
Congress Advances Rare Disease & Cancer Innovation
Posted In: Federal Advocacy,
Date posted Feb 6

In overlapping victories for biotech innovation and public health, the U.S. Senate and House of Representatives have approved two landmark pieces...

Read Post